The objective of this study was to evaluate whether modifiable cardiovascular risk conditions and lifestyle factors were temporally associated with an increased risk for ischemic heart disease and overall mortality in a cohort of hematopoietic cell transplantation (HCT) survivors. METHODS: HCT recipients who had survived for 1 year, were 20 years old, and had undergone transplantation between 1970 and 2010 at a transplant referral center were surveyed in 2010-2011 about cardiovascular health and lifestyle factors (n 5 3833). Respondents (n 5 2360 [61.6%]) were followed to 2016 for incident ischemic heart disease and overall mortality. RESULTS: Among the 2360 transplant survivors (median age at the baseline survey, 55.9 years; median time since transplantation, 10.8 years), 162 (6.9%) reported ischemic heart disease at the baseline survey. Among those without ischemic heart disease at the baseline survey (n 5 2198), the 5-year cumulative incidence of subsequent ischemic heart disease was 4.3%. Obesity, dyslipidemia, diabetes, and physical inactivity at baseline were associated with an increased risk for subsequent ischemic heart disease (hazard ratio [HRs] 1.8). Greater physical activity and fruit/vegetable intake at baseline were associated with subsequent lower overall mortality (HRs 0.7). When jointly considered, each additional cardiovascular risk condition and each adverse lifestyle factor were independently associated with subsequent ischemic heart disease (HR for risk conditions, 1.4; 95% confidence interval [CI], 1.0-1.9; HR for lifestyle factors, 1.9; 95% CI, 1.2-2.9), and adverse lifestyle factors remained associated with overall mortality (HR, 1.8; 95% CI, 1.5-2.3). CONCLUSIONS: These results support strong efforts to promote healthy lifestyle behaviors and to treat cardiovascular risk factors aggressively in HCT survivors. This may reduce future ischemic heart disease and overall mortality in this high-risk population. Cancer 2018;124:1507-15.
INTRODUCTION
The increasing prevalence and effectiveness of hematopoietic cell transplantation (HCT) have resulted in a growing population of long-term survivors of HCT. 1 Unfortunately, HCT survivors suffer numerous long-term complications from their therapy, and cardiovascular disease is among the most significant of these complications. 2, 3 HCT survivors experience a significantly greater incidence of cardiovascular morbidity and mortality in comparison with the general population. 4, 5 Specifically, cardiovascular mortality may be twice as common as expected in the general population; in 5-year HCT survivors, it accounted for 7% of excess deaths and came behind new malignancies or recurrence (approximately 50% of excess deaths), late infections (18%), chronic graft-versus-host disease (GVHD; 12%), and respiratory disease (8%). 2 Compared with the general population, HCT survivors also have a higher burden of potentially modifiable conditions such as hypertension, dyslipidemia, and diabetes that further increase the risk for subsequent serious cardiovascular disease. [5] [6] [7] Our group has previously demonstrated that adverse lifestyle factors such as low physical activity, low fruit and vegetable intake, and smoking also remain significant modifiable risk factors associated with both serious cardiovascular events such as ischemic heart disease and related conditions such as dyslipidemia, diabetes, and hypertension. 8 Although these cross-sectional associations between lifestyle and adverse cardiovascular conditions were significant, establishing a temporal relation would provide stronger evidence for clinicians to treat these conditions more aggressively and to promote healthy lifestyle changes in survivors. Thus, the aim of this longitudinal study was to determine whether modifiable cardiovascular risk conditions and lifestyle factors are associated with subsequent increased risk for ischemic heart disease and overall mortality among HCT survivors. Positive findings would also provide additional support for interventions to improve adherence to cardiovascular risk factor treatment and lifestyle modifications in this high-risk population.
MATERIALS AND METHODS

Study Population
All patients who have previously undergone HCT at the Fred Hutchinson Cancer Research Center (FHCRC) and have signed informed consent for research follow-up are mailed an annual health status survey on the anniversary of their transplant. Between July 2010 and September 2011, this survey contained supplemental questions focused on cardiovascular health. As previously described, 3833 patients who were 20 years old and transplanted between 1970 and 2010 were surveyed during that interval, and 2360 (61.6%) responded. 8 Follow-up surveys have been sent to this group annually. As of March 31, 2016 March 31, , 1921 of the 2360 participants (81.4%) had returned at least 1 subsequent survey. The FHCRC HCT program maintains a database that records demographics (age, sex, and race/ ethnicity) and treatment-related characteristics (underlying disease; HCT conditioning regimen, including total body irradiation and cyclophosphamide exposures; donor type [autologous or allogeneic]; GVHD prophylaxis [steroids, calcineurin inhibitors, and rapamycin]; and acute and chronic GVHD status) of all HCT recipients.
Survey Instrument and Definitions
The baseline survey (2010-2011; available upon request) asked participants to report on their history (including age of onset) of serious cardiovascular events (eg, ischemic heart disease, cardiomyopathy/heart failure, and stroke) and related conditions (eg, hypertension, dyslipidemia, and diabetes), their current height and weight, and their family history (first-degree relatives) of cardiovascular disease. Using questions adapted from the National Health and Nutrition Examination Survey of the Centers for Disease Control and Prevention (CDC), 9 the baseline survey also assessed smoking and tobacco use (never used, previously but no longer used, or currently used), weekly time spent in recreational physical activity, and average daily fruit and vegetable intake.
Self-reported height and weight were converted into the body mass index, and patients were categorized as underweight, normal, overweight, or obese (<18.5, 18.5-24.9, 25.0-29.9, and 30.0 kg/m 2 , respectively). For recreational physical activity, the self-reported amount of time spent doing vigorous and moderate activities during the past week was summed, with every 2 minutes of moderate activity equivalent to 1 minute of vigorous activity. Respondents were categorized as meeting or not meeting CDC recommendations for aerobic activities: 75 minutes per week of vigorous activity, 150 minutes per week of moderate activity, or an equivalent mixture of both. We also examined physical activity time on the basis of tertiles (with respondents without any moderate or vigorous activity serving as the reference). For diet, in addition to the determination of the daily number of fruit and vegetable servings, respondents also were categorized as meeting or not meeting national recommendations for at least 5 daily servings. 10 Subsequent limited annual surveys assessed the development of ischemic heart disease plus other outcomes such as new cancers and original disease recurrence, chronic GVHD (if allogeneic HCT had been performed), and infections. Vital status was prospectively tracked by FHCRC via annual contact with patients and families, referring providers, and periodic searches of public sources for patients without recent contact. For patients who died during the observation period, available records were reviewed to determine whether their death could be attributable to ischemic heart disease. The FHCRC institutional review board approved all procedures.
Statistical Analysis
We calculated the prevalence of baseline characteristics, adverse lifestyle factors (ie, current smoking, <5 fruit/vegetable servings per day, and not meeting CDC exercise recommendations), and cardiovascular risk conditions (ie, obesity, hypertension, dyslipidemia, and diabetes) among the HCT survivors with and without prior ischemic heart disease. Differences between the 2 groups were assessed with univariate methods. The 5-year cumulative incidences of ischemic heart disease and all-cause mortality also were plotted. Limited to those without ischemic heart disease at the time of the baseline survey, a series of Cox proportional hazards models (starting at the time of the baseline survey) examined the association (hazard ratios [HRs] ) between each baseline cardiovascular condition or lifestyle factor and the subsequent risks of ischemic heart disease and overall mortality. Similar to our prior analysis, 8 these models adjusted for sex, race/ethnicity, age at the baseline survey, HCT donor type, history of chronic GVHD, years that elapsed between HCT and the baseline survey, and family history of cardiovascular and related diseases. We also separately examined the influence of total body irradiation and cyclophosphamide conditioning and agents used for GVHD prophylaxis.
To examine the cumulative effect of risk factors, variables were created that summed the number of cardiovascular risk conditions (0, 1, 2, and 3) and the number of adverse lifestyle factors (0, 1, and 2). In the analysis of ischemic heart disease, death due to other causes was treated as a competing risk event.
Given the growing role of cardiovascular risk calculators in general practice, in a secondary analysis, we applied the simple non-laboratory-based Framingham general cardiovascular risk scores to HCT survivors who were 30 years old at the baseline survey. 11 These risk scores were assigned on the basis of age, sex, current smoking status, presence of obesity (based on the body mass index), blood pressures and use of antihypertensive medications, and history of diabetes. Because we did not have actual systolic blood pressure values, we made the conservative assumption that those not treated with antihypertensive medications had normal blood pressures and similarly that those treated with antihypertensives were well controlled, with their pressures now within the normal range. Because the number of outcomes available for analysis was limited, we categorized risk scores into the following 10-year predicted risk categories: <5%, 5% to 9%, 10% to 19%, and 20%. Cox models that examined the relation between Framingham risk score categories and subsequent ischemic heart disease and overall mortality were unadjusted because the Framingham scores already accounted for sex and age.
All analyses were performed with Stata (version 14; StataCorp, College Station, Texas). Global tests of proportionality, based on Schoenfeld residuals, ensured that proportional hazards assumptions were met (P .05); covariates with nonproportional hazards were treated as time-varying. 12 
RESULTS
For the 2360 HCT survivors who were analyzed (median age at baseline survey 55.9 years, range, 20.2-83.3), a median of 10.8 years (range, 0.9-40.4 years) had passed since HCT at the time of our baseline cardiovascular survey. One hundred sixty-two of these survivors (6.9%) Lifestyle and Heart Disease After HCT/Leger et al
already had a history of ischemic heart disease. Compared with those without prior ischemic heart disease at the time of the baseline survey, those affected were more often male and older at the time of both the transplant and the baseline study assessment and were more likely to have a history of chronic GVHD (Table 1) . Those with prior ischemic heart disease also had a significantly greater baseline burden of hypertension, dyslipidemia, and diabetes (all P values < .05). Although baseline smoking rates and fruit/vegetable intake were similar between these 2 groups, those with prior ischemic heart disease were much less physically active. They also were more likely to die during follow-up (24.1% vs 12.6%; P < .001). At 5 years, the cumulative incidences of overall mortality were 28.2% and 15.2% for these 2 groups (P for the difference < .0001; Fig. 1 ). Among surviving participants, the median durations of follow-up after the baseline survey were similar for those with and without prior ischemic heart disease (4.8 vs 4.7 years; range, 0.1-5.9 years). Although individuals without prior ischemic heart disease (n 5 2198) at the baseline survey had a significantly lower burden of adverse cardiovascular conditions, more than 30% of these survivors still had 2 or more adverse lifestyle factors present (Table 2 ). More than 50% of these survivors had a predicted 10-year general cardiovascular risk of at least 10%. The 5-year cumulative incidence of ischemic heart disease in survivors without prior ischemic heart disease was 4.3% (95% confidence interval [CI], 3.0%-6.0%). When the cumulative incidence rates of ischemic heart disease and overall mortality, stratified by the number of adverse cardiovascular conditions and the number of lifestyle factors, were plotted, these characteristics were generally associated with a differential risk for both outcomes (P .01 for all comparisons except for the number of cardiovascular conditions and mortality; Fig. 2 ). Although our follow-up was limited, the cumulative incidence rates increased without evidence of a plateau.
Among those without ischemic heart disease at the baseline survey, obesity, hypertension, dyslipidemia, and diabetes were associated with an increased risk for subsequent ischemic heart disease, with an approximate doubling of the hazards associated with each condition (P for trend < .0001; Table 3 ). The association between these cardiovascular conditions and overall mortality was less striking, although an underweight body mass index status and diabetes were significantly associated with the mortality risk.
In contrast, increased levels of physical activity were associated with at least a 50% lower hazard of both ischemic heart disease and overall mortality (Table 3 ). Cumulative incidence of all-cause mortality over 5 years stratified by the presence or absence of ischemic heart disease at the baseline survey and cumulative incidence of new-onset ischemic heart disease.The difference in mortality by ischemic heart disease history was significant (log-rank P < .0001). Data were incomplete for 123 HCT recipients without prior ischemic heart disease.
Although estimates for greater fruit/vegetable intake and current smoking did not meet statistical significance in all instances, they were associated with lower and higher hazards of outcomes, respectively. This included a 30% lower risk of death associated with greater fruit/vegetable intake. When all 3 lifestyle factors were analyzed in combination, survivors who had multiple adverse lifestyle factors at baseline were significantly more likely to experience subsequent ischemic heart disease and death from any cause (HRs with 2 or more factors present vs none, >3; P for trend < .01). When the numbers of adverse cardiovascular risk conditions and lifestyle factors were analyzed jointly, both remained significantly associated with a higher hazard of subsequent ischemic heart disease (HR for risk conditions, 1.4; 95% CI, 1.0-1.9; HR for lifestyle factors, 1.9; 95% CI, 1.2-2.9). However, although lifestyle factors remained associated with a higher hazard of overall mortality (HR, 1.8; 95% CI, 1.5-2.3), cardiovascular risk conditions were not (HR, 1.0; 95% CI, 0.9-1.2). Although HRs for ischemic heart disease were increased for males, an older age at the time of the baseline survey, a longer time since transplantation, autologous recipients, and a history of chronic GVHD, none of these associations were statistically significant (Supporting Table 1 [see online supporting information]). Although statistical power to identify an association may be limited for some of these exposures, we also did not find total body irradiation, cyclophosphamide-containing conditioning regimens, or specific agents used for GVHD prophylaxis (steroids, calcineurin inhibitors, and rapamycin) to be associated with a subsequent risk of ischemic heart disease (data not shown).
Higher Framingham risk scores also were associated with greater risks of both ischemic heart disease and overall mortality, although the association appeared to be stronger for ischemic heart disease ( Table 3) . To address the possibility that the associations between cardiovascular conditions, lifestyle factors, and subsequent ischemic heart disease and overall mortality could be influenced by survivors with a history of post-HCT relapse, we conducted sensitivity analyses that excluded those with post-HCT relapse (n 5 255; median time of relapse before the baseline survey, 7.3 years). An increasing number of adverse lifestyle factors remained significantly associated with subsequent ischemic heart disease and overall mortality (HR for each additional factor present, 1.6; P for both outcomes < .05).
Finally, we examined the characteristics of those who returned a subsequent survey after our baseline assessment and those who did not. Those without a Figure 2 . Cumulative incidence of ischemic heart disease over 5 years stratified by the number of (A) cardiovascular risk conditions and (B) adverse lifestyle factors, and cumulative incidence of overall mortality stratified by the number of (C) cardiovascular risk conditions and (D) adverse lifestyle factors among hematopoietic cell transplant survivors without prior ischemic heart disease (n 5 2198). Global differences in incidence were determined by the Fine-Gray method (ischemic heart disease) or logrank testing (overall mortality).
subsequent survey response after the baseline assessment were more likely to die during follow-up (30.5% vs 9.5%). They included 63 who died within 1 year of the baseline survey and would not have had an opportunity to return a subsequent survey. Among those who had survived 1 year since the baseline survey, those without a subsequent survey response (n 5 376) were more likely to be male (58.0% vs 51.7%) and slightly younger at baseline (median age, 51.8 vs 56.5 years) in comparison with responders. Although these nonresponders were less likely to report 2 or more adverse cardiovascular conditions at baseline (21.3% vs 27.3%), they were more likely to have 2 or more adverse lifestyle factors at baseline (39.5% vs 29.8%).
DISCUSSION
Our prospective, longitudinal study showed that potentially modifiable cardiovascular risk conditions and adverse lifestyle factors remain associated with the subsequent risk of ischemic heart disease and overall mortality in a HCT survivor population. For both risk conditions and lifestyle factors, we also identified a significant doseresponse relation with ischemic heart disease. A doseresponse relation also was observed between adverse lifestyle factors and overall mortality. Our results suggest that the influence of adverse lifestyle factors on both ischemic heart disease and overall mortality among HCT survivors could be as significant as, if not more significant than, the influence of cardiovascular risk conditions. Importantly, these associations were observed with only 5 years of follow-up. The development of clinical interventions to control cardiovascular risk conditions and promote healthier lifestyles could improve outcomes in this highrisk population. Among HCT survivors free of ischemic heart disease at baseline, we observed an approximately 4% cumulative incidence of new ischemic heart disease after 5 years.
Although not all data were available for the assignment of Framingham general cardiovascular risk scores, 11 at least 50% of our study population free of ischemic heart disease at baseline had a predicted 10% or greater risk of having a serious cardiovascular event within the next 10 years. This risk may be underestimated because of our conservative assumption that those who were treated with antihypertensives had good blood pressure control and that no HCT survivor had undiagnosed hypertension. Cardiovascular risk scores developed for the general population also do not consider cancer treatments such as radiation and select chemotherapy that may further increase the risk of cardiovascular disease. 13, 14 At the same time, our prior research suggests that HCT survivors reported healthier lifestyle habits than a matched general population sample, and this may have attenuated cardiovascular disease risk. 8 Multiple studies have now demonstrated that HCT survivors have a greater burden of potentially modifiable cardiovascular risk conditions in comparison with the general population. [5] [6] [7] 15 Furthermore, HCT survivors who are affected by these conditions before transplantation or who develop them in the years after transplantation experience a greater risk of a subsequent serious cardiovascular event. 5, 7 Although dyslipidemia and other metabolic abnormalities are common after transplantation, often as a side effect of immunosuppressive treatment for GVHD, some of these abnormalities may resolve after immunosuppressive treatment has ended. 7, 16 Nevertheless, laboratory data from HCT survivors' 1-year posttransplant visits suggest that those with higher total cholesterol and triglyceride serum concentrations may be more likely to experience a subsequent serious cardiovascular event. 7 Because it is difficult to predict in advance whether hypertension, dyslipidemia, or diabetes that develops soon after HCT will later self-resolve, tighter control of these cardiovascular risk conditions soon after they manifest may be more appropriate than watchful waiting. Certainly, HCT survivors who have preexisting cardiovascular risk conditions should continue to be monitored closely and treated for these conditions. Studies of breast cancer patients treated in a large health maintenance organization suggest that control of cardiovascular conditions often worsens during cancer treatment, and adherence to cardiovascular medications may not return to precancer levels even after the completion of active cancer treatment. 17, 18 The association of adverse lifestyle factors with subsequent cardiovascular disease has not been well studied in cancer survivors. A multi-institutional European study of more than 500 HCT survivors found that those who experienced subsequent arterial events were less physically active and more likely to have continued smoking after HCT. 15 In other studies, obesity and physical inactivity were linked to the subsequent development of cardiovascular disease in colorectal cancer survivors, 19 and higher levels of vigorous activity were associated with overall better health in testicular cancer survivors. 20 Increased physical activity also has been found to be protective against the subsequent risk of serious cardiovascular events in childhood Hodgkin lymphoma survivors in a dose-dependent fashion. 21 Other lifestyle factors such as diet may also be influential. For example, increased adherence to a healthier diet (eg, a Mediterranean diet pattern) was associated with lower adiposity and a lower risk of metabolic syndrome in previously irradiated childhood leukemia survivors. 22 Finally, overall increased adherence to lifestyle-related cancer prevention recommendations (eg, maintaining a lean body weight, being physically active, and eating a healthier diet) has been associated with lower overall mortality in older female cancer survivors. 23 Like our study, these studies also relied on self-reporting.
Although the interpretation of our results is strengthened by the prospective, longitudinal design and the large sample size, our study also has some limitations. Most cases of ischemic heart disease were self-reported. However, a previous study has shown that HCT survivors can report ischemic heart disease reasonably accurately in comparison with a medical record review. 24 Our questions regarding lifestyle factors were all adapted from wellvalidated national surveys. Although it is possible that the results could be subject to a response bias, the overall response rate during the follow-up period was high (>80%), and our mortality analysis should be relatively free from such bias. Finally, although the overall duration of follow-up was only 5 years, we already observed a robust association between cardiovascular risk conditions, lifestyle factors, and subsequent ischemic heart disease during this time. Other studies of HCT survivors and other cancer survivors with longer follow-up do not suggest that the increased burden of cardiovascular and other late effects plateaus over time. 4, [25] [26] [27] Overall, our results support the importance of healthy lifestyle choices for cancer survivors, including those treated with HCT, and more aggressive screening and treatment of potentially modifiable cardiovascular risk conditions. [28] [29] [30] Patients may use the cancer experience as motivation to adopt healthier lifestyles. 31 Clinicians should leverage this opportunity to foster these changes. A growing body of evidence suggests that interventions designed to improve diet and increase physical activity in cancer survivors can lead to short-and medium-term improvements. [32] [33] [34] [35] More research is needed to determine whether such improvements can persist in the longer term with meaningful impacts on subsequent health and quality of life.
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